This page requires JavaScript to display.

Anthropic buys Mithril Medicine

AI & tech · Heat 6.9 / 10 · 3 shows · 13m airtime

Anthropic announced on October 27, 2026, a drug discovery partnership with Bristol-Myers Squibb and its acquisition of Mithril Medicine, a biotech founded by one person. The founder used Claude and part-time consultants to take a muscular dystrophy antibody from concept to mouse proof of principle in 18 months, and Anthropic says it could be trial-ready by the end of 2028. The discussion has since widened: the 326-page IPO paperwork uses the word reputation 103 times, and disclosed acquisitions total about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed. Whether the deal is validation or marketing ahead of the listing remains contested.

How 3 podcasts covered it

  1. The AI Daily Brief, 2026-10-28 (1:27 to 6:16)
    Covers the acquisition and rounds up the reaction
    Covers Anthropic's drug discovery blog post, the Bristol-Myers Squibb partnership and the Mithril Medicine acquisition, then rounds up the reaction: the one-person-company debate, Scorpion Capital's dig at the founder's banking background, and the read that it is IPO marketing.
    New angle: Anthropic acquired Mithril Medicine, a one-person biotech whose founder used Claude to reach mouse proof of principle on a muscular dystrophy antibody in 18 months.
  2. The Best One Yet, 2026-10-29 (10:29 to 14:53)
    Recasts the acquisition as a solopreneur story
    Tells the acquisition as a solopreneur story: the anonymous @prof_oak_ turns out to be Cody Tranbarger, who ran 11 labs with Claude as his staff. Reads the deal as a reputation play, counting the word reputation 103 times in Anthropic's 326-page IPO paperwork.
    New angle: Anthropic's 326-page IPO paperwork uses the word reputation 103 times.
  3. Equity, 2026-10-30 (17:31 to 21:26)
    Puts a $737M figure on the acquisitions
    Walks the S-1's acquisition line and puts a number on it: about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed. Frames the buying as part of a perpetual growth machine that has to keep spending on compute.
    New angle: Anthropic's disclosed acquisitions total about $737 million excluding Coefficient Bio, with roughly $260 million undisclosed.
Unpacking...